This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Tel Aviv University. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Yana Epshtein: Innovator in Cancer Therapeutics
Introduction
Yana Epshtein is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of cancer therapeutics, particularly in the development of polymeric systems for treating melanoma and other cancerous diseases. With a total of 2 patents, her work is paving the way for innovative treatment methodologies.
Latest Patents
Epshtein's latest patents include groundbreaking research on polymeric conjugates and their applications. One patent focuses on polymeric conjugates that comprise a polymeric matrix associated with an agent that down-regulates the activity or expression of a polypeptide linked to the onset or progression of melanoma. This patent also discusses synthetic methodologies for preparing these conjugates and their uses in treating melanoma and other cancerous diseases. Another patent highlights polymeric systems designed for theranostic applications. These systems incorporate a fluorescent or fluorogenic moiety and a therapeutically active agent, generating a fluorescent signal in response to a chemical event, particularly when interacting with an analyte over-expressed in diseased tissues or organs.
Career Highlights
Yana Epshtein is affiliated with Tel Aviv University, where she conducts her research and development work. Her innovative approaches in cancer treatment have garnered attention in the scientific community, contributing to advancements in therapeutic strategies.
Collaborations
Epshtein collaborates with notable colleagues, including Ronit Satchi-Fainaro and Doron Shabat. These partnerships enhance her research efforts and expand the impact of her inventions in the field of cancer therapeutics.
Conclusion
Yana Epshtein's contributions to cancer research through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic applications for cancer treatment.